TEVA logo

TEVA Depreciation And Amortization

Annual D&A

$1.06 B
-$94.00 M-8.15%

December 31, 2024

Summary

Performance

1-Year Change

-8.15%

3-Year Change

-20.38%

5-Year Change

-38.5%

15-Year Change

-49.86%

TEVA Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.49%
TEVA annual depreciation & amortization is higher than 97.49% of companies in Healthcare sector

High & Low

All-time High

$2.11 B
TEVA annual depreciation & amortization is currently -49.86% below its historical high of $2.11 billion

3-Year Low

$1.06 B
TEVA annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
TEVA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
TEVA next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$13.18 B
TEVA annual total expenses is $13.18 billion

Annual Operating Expenses

$4.70 B
TEVA annual total operating expenses is $4.70 billion

Annual Cost Of Goods Sold

$8.48 B
TEVA annual cost of goods sold is $8.48 billion

Annual Interest Expense

$1.00 B
TEVA annual interest expense is $1.00 billion

Quarterly D&A

$269.00 M
+$10.00 M+3.86%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

TEVA Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.13%
TEVA quarterly depreciation & amortization is higher than 98.13% of companies in Healthcare sector

High & Low

All-time High

$577.00 M
TEVA quarterly depreciation & amortization is currently -53.38% below its historical high of $577.00 million

3-Year Low

$259.00 M
TEVA quarterly depreciation & amortization is currently +3.86% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TEVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
TEVA next earnings announcement is scheduled for May 8, 2025

Related metrics

Quarterly Total Expenses

$3.31 B
TEVA quarterly total expenses is $3.31 billion

Quarterly Operating Expenses

$1.20 B
TEVA quarterly total operating expenses is $1.20 billion

Quarterly Cost Of Goods Sold

$2.11 B
TEVA quarterly cost of goods sold is $2.11 billion

Quarterly Interest Expense

$239.00 M
TEVA quarterly interest expense is $239.00 million

TTM D&A

$1.06 B
+$3.00 M+0.28%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

TEVA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.03%
TEVA TTM depreciation & amortization is higher than 98.03% of companies in Healthcare sector

High & Low

All-time High

$2.14 B
TEVA TTM depreciation & amortization is currently -50.49% below its historical high of $2.14 billion

3-Year Low

$1.06 B
TEVA TTM depreciation & amortization is currently +0.28% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TEVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
TEVA next earnings announcement is scheduled for May 8, 2025

Related metrics

Annual Total Expenses

$13.18 B
TEVA annual total expenses is $13.18 billion

Annual Operating Expenses

$4.70 B
TEVA annual total operating expenses is $4.70 billion

TTM Cost Of Goods Sold

$8.48 B
TEVA TTM cost of goods sold is $8.48 billion

TTM Interest Expense

$1.00 B
TEVA TTM interest expense is $1.00 billion

TEVA Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.2%0.0%0.0%
3 y3 years-20.4%0.0%0.0%
5 y5 years-38.5%0.0%0.0%

TEVA Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-20.4%at low-24.9%+3.9%-20.4%+0.3%
5 y5-year-38.5%at low-35.3%+3.9%-38.5%+0.3%
alltimeall time-49.9%+7573.9%-53.4%+584.7%-50.5%-100.0%

Teva Pharmaceutical Industries Limited Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$1.06 B(-8.2%)
$269.00 M(+3.9%)
$1.06 B(+0.3%)
Sep 2024
-
$259.00 M(0.0%)
$1.06 B(-2.2%)
Jun 2024
-
$259.00 M(-4.8%)
$1.08 B(-3.7%)
Mar 2024
-
$272.00 M(+2.3%)
$1.12 B(-2.8%)
Dec 2023
$1.15 B(-11.9%)
$266.00 M(-6.0%)
$1.15 B(-3.4%)
Sep 2023
-
$283.00 M(-5.7%)
$1.19 B(-3.1%)
Jun 2023
-
$300.00 M(-1.3%)
$1.23 B(-4.5%)
Mar 2023
-
$304.00 M(-0.7%)
$1.29 B(-1.5%)
Dec 2022
$1.31 B(-1.7%)
$306.00 M(-4.7%)
$1.31 B(-1.1%)
Sep 2022
-
$321.00 M(-10.3%)
$1.32 B(-0.6%)
Jun 2022
-
$358.00 M(+10.8%)
$1.33 B(+4.2%)
Mar 2022
-
$323.00 M(+0.9%)
$1.28 B(-4.0%)
Dec 2021
$1.33 B(-14.6%)
$320.00 M(-2.7%)
$1.33 B(-5.3%)
Sep 2021
-
$329.00 M(+7.9%)
$1.41 B(-3.6%)
Jun 2021
-
$305.00 M(-18.9%)
$1.46 B(-5.0%)
Mar 2021
-
$376.00 M(-4.8%)
$1.53 B(-1.5%)
Dec 2020
$1.56 B(-9.6%)
$395.00 M(+3.7%)
$1.56 B(-1.3%)
Sep 2020
-
$381.00 M(-0.3%)
$1.58 B(-2.0%)
Jun 2020
-
$382.00 M(-4.3%)
$1.61 B(-4.1%)
Mar 2020
-
$399.00 M(-4.1%)
$1.68 B(-2.6%)
Dec 2019
$1.72 B(-6.5%)
$416.00 M(+0.7%)
$1.72 B(+2.0%)
Sep 2019
-
$413.00 M(-8.2%)
$1.69 B(-3.5%)
Jun 2019
-
$450.00 M(+1.6%)
$1.75 B(-1.6%)
Mar 2019
-
$443.00 M(+16.0%)
$1.78 B(-3.5%)
Dec 2018
$1.84 B(-12.8%)
$382.00 M(-19.4%)
$1.84 B(-7.3%)
Sep 2018
-
$474.00 M(-1.0%)
$1.99 B(-2.6%)
Jun 2018
-
$479.00 M(-5.5%)
$2.04 B(-4.6%)
Mar 2018
-
$507.00 M(-4.0%)
$2.14 B(+1.3%)
Dec 2017
$2.11 B(+38.6%)
$528.00 M(+0.2%)
$2.11 B(+10.2%)
Sep 2017
-
$527.00 M(-8.7%)
$1.92 B(-2.5%)
Jun 2017
-
$577.00 M(+20.2%)
$1.97 B(+15.7%)
Mar 2017
-
$480.00 M(+44.6%)
$1.70 B(+11.5%)
Dec 2016
$1.52 B(+16.5%)
$332.00 M(-42.5%)
$1.52 B(-0.2%)
Sep 2016
-
$577.00 M(+86.1%)
$1.53 B(+20.7%)
Jun 2016
-
$310.00 M(+1.6%)
$1.26 B(-1.0%)
Mar 2016
-
$305.00 M(-9.0%)
$1.28 B(-2.3%)
Dec 2015
$1.31 B(-13.3%)
$335.00 M(+6.3%)
$1.31 B(-2.5%)
Sep 2015
-
$315.00 M(-2.5%)
$1.34 B(-3.3%)
Jun 2015
-
$323.00 M(-3.6%)
$1.39 B(-3.5%)
Mar 2015
-
$335.00 M(-9.2%)
$1.44 B(-4.6%)
Dec 2014
$1.51 B(-8.2%)
$369.00 M(+2.2%)
$1.51 B(-4.3%)
Sep 2014
-
$361.00 M(-3.5%)
$1.57 B(-3.6%)
Jun 2014
-
$374.00 M(-7.4%)
$1.63 B(-1.6%)
Mar 2014
-
$404.00 M(-7.3%)
$1.66 B(+1.0%)
Dec 2013
$1.64 B
$436.00 M(+4.1%)
$1.64 B(+2.7%)
Sep 2013
-
$419.00 M(+4.8%)
$1.60 B(+0.4%)
DateAnnualQuarterlyTTM
Jun 2013
-
$400.00 M(+3.4%)
$1.59 B(+1.0%)
Mar 2013
-
$387.00 M(-1.5%)
$1.58 B(-7.7%)
Dec 2012
$1.71 B(+59.8%)
$393.00 M(-4.6%)
$1.71 B(+3.7%)
Sep 2012
-
$412.00 M(+7.3%)
$1.65 B(+11.1%)
Jun 2012
-
$384.00 M(-26.0%)
$1.48 B(+12.1%)
Mar 2012
-
$519.00 M(+56.3%)
$1.32 B(+23.7%)
Dec 2011
$1.07 B(+9.4%)
$332.00 M(+34.4%)
$1.07 B(+8.3%)
Sep 2011
-
$247.00 M(+10.3%)
$987.00 M(-1.2%)
Jun 2011
-
$224.00 M(-15.8%)
$999.00 M(-0.9%)
Mar 2011
-
$266.00 M(+6.4%)
$1.01 B(+3.2%)
Dec 2010
$977.00 M(+7.6%)
$250.00 M(-3.5%)
$977.00 M(+1.0%)
Sep 2010
-
$259.00 M(+11.2%)
$967.00 M(+0.5%)
Jun 2010
-
$233.00 M(-0.9%)
$962.00 M(-15.8%)
Mar 2010
-
$235.00 M(-2.1%)
$1.14 B(+25.9%)
Dec 2009
$908.00 M(+84.2%)
$240.00 M(-5.5%)
$908.00 M(+15.5%)
Sep 2009
-
$254.00 M(-38.6%)
$786.00 M(+19.3%)
Jun 2009
-
$414.00 M(+250.8%)
$659.00 M(+33.7%)
Dec 2008
$493.00 M(-5.4%)
$118.00 M(-7.1%)
$493.00 M(-4.3%)
Sep 2008
-
$127.00 M(+4.1%)
$515.00 M(+2.6%)
Jun 2008
-
$122.00 M(-3.2%)
$502.00 M(-1.6%)
Mar 2008
-
$126.00 M(-10.0%)
$510.00 M(-2.1%)
Dec 2007
$521.00 M(+20.9%)
$140.00 M(+22.8%)
$521.00 M(+7.4%)
Sep 2007
-
$114.00 M(-12.3%)
$485.00 M(+0.8%)
Jun 2007
-
$130.00 M(-5.1%)
$481.10 M(+0.0%)
Mar 2007
-
$137.00 M(+31.7%)
$481.00 M(+11.6%)
Dec 2006
$431.00 M(+77.4%)
$104.00 M(-5.5%)
$431.00 M(-24.4%)
Sep 2006
-
$110.10 M(-15.2%)
$570.00 M(+23.9%)
Jun 2006
-
$129.90 M(+49.3%)
$459.90 M(+67.5%)
Mar 2006
-
$87.00 M(-64.2%)
$274.50 M(+13.0%)
Dec 2005
$243.00 M(+11.5%)
$243.00 M(-537.8%)
$243.00 M(>+9900.0%)
Jun 2005
-
-$55.50 M(-200.0%)
$0.00(-100.0%)
Mar 2005
-
$55.50 M
$55.50 M
Dec 2004
$218.00 M(+70.7%)
-
-
Dec 2003
$127.70 M(+31.8%)
-
-
Dec 2002
$96.90 M(-11.2%)
-
-
Dec 2001
$109.13 M(+14.9%)
-
-
Dec 2000
$94.98 M(+38.8%)
-
-
Dec 1999
$68.42 M(+16.5%)
-
-
Dec 1998
$58.74 M(+13.0%)
-
-
Dec 1997
$52.00 M(+19.0%)
-
-
Dec 1996
$43.70 M(+32.4%)
-
-
Dec 1995
$33.00 M(+7.1%)
-
-
Dec 1994
$30.80 M(+57.1%)
-
-
Dec 1993
$19.60 M(+8.3%)
-
-
Dec 1992
$18.10 M(+31.2%)
-
-
Dec 1991
$13.80 M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual depreciation & amortization?
  • What is the all time high annual D&A for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual D&A year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly D&A year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM depreciation & amortization?
  • What is the all time high TTM D&A for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM D&A year-on-year change?

What is Teva Pharmaceutical Industries Limited annual depreciation & amortization?

The current annual D&A of TEVA is $1.06 B

What is the all time high annual D&A for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual depreciation & amortization is $2.11 B

What is Teva Pharmaceutical Industries Limited annual D&A year-on-year change?

Over the past year, TEVA annual depreciation & amortization has changed by -$94.00 M (-8.15%)

What is Teva Pharmaceutical Industries Limited quarterly depreciation & amortization?

The current quarterly D&A of TEVA is $269.00 M

What is the all time high quarterly D&A for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly depreciation & amortization is $577.00 M

What is Teva Pharmaceutical Industries Limited quarterly D&A year-on-year change?

Over the past year, TEVA quarterly depreciation & amortization has changed by $0.00 (0.00%)

What is Teva Pharmaceutical Industries Limited TTM depreciation & amortization?

The current TTM D&A of TEVA is $1.06 B

What is the all time high TTM D&A for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM depreciation & amortization is $2.14 B

What is Teva Pharmaceutical Industries Limited TTM D&A year-on-year change?

Over the past year, TEVA TTM depreciation & amortization has changed by $0.00 (0.00%)